These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33045468)

  • 41. Nicotinamide phosphoribosyltransferase (Nampt) in carcinogenesis: new clinical opportunities.
    Chen H; Wang S; Zhang H; Nice EC; Huang C
    Expert Rev Anticancer Ther; 2016 Aug; 16(8):827-38. PubMed ID: 27186719
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail group.
    Travelli C; Aprile S; Mattoteia D; Colombo G; Clemente N; Scanziani E; Terrazzino S; Alisi MA; Polenzani L; Grosa G; Genazzani AA; Tron GC; Galli U
    Eur J Med Chem; 2019 Nov; 181():111576. PubMed ID: 31400709
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia.
    Audrito V; Serra S; Brusa D; Mazzola F; Arruga F; Vaisitti T; Coscia M; Maffei R; Rossi D; Wang T; Inghirami G; Rizzi M; Gaidano G; Garcia JG; Wolberger C; Raffaelli N; Deaglio S
    Blood; 2015 Jan; 125(1):111-23. PubMed ID: 25368373
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endothelial eNAMPT drives EndMT and preclinical PH: rescue by an eNAMPT-neutralizing mAb.
    Ahmed M; Zaghloul N; Zimmerman P; Casanova NG; Sun X; Song JH; Hernon VR; Sammani S; Rischard F; Rafikova O; Rafikov R; Makino A; Kempf CL; Camp SM; Wang J; Desai AA; Lussier Y; Yuan JX; Garcia JGN
    Pulm Circ; 2021; 11(4):20458940211059712. PubMed ID: 34790349
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular insights into the interaction between human nicotinamide phosphoribosyltransferase and Toll-like receptor 4.
    Gasparrini M; Mazzola F; Cuccioloni M; Sorci L; Audrito V; Zamporlini F; Fortunato C; Amici A; Cianci M; Deaglio S; Angeletti M; Raffaelli N
    J Biol Chem; 2022 Mar; 298(3):101669. PubMed ID: 35120922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma.
    Audrito V; Managò A; Zamporlini F; Rulli E; Gaudino F; Madonna G; D'Atri S; Antonini Cappellini GC; Ascierto PA; Massi D; Raffaelli N; Mandalà M; Deaglio S
    Oncotarget; 2018 Apr; 9(27):18997-19005. PubMed ID: 29721178
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extracellular Nicotinamide Phosphoribosyltransferase Is a Therapeutic Target in Experimental Necrotizing Enterocolitis.
    Halpern MD; Gupta A; Zaghloul N; Thulasingam S; Calton CM; Camp SM; Garcia JGN; Ahmed M
    Biomedicines; 2024 Apr; 12(5):. PubMed ID: 38790933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Role of Nicotinamide Phosphoribosyltransferase in Cerebral Ischemia.
    Chen X; Zhao S; Song Y; Shi Y; Leak RK; Cao G
    Curr Top Med Chem; 2015; 15(21):2211-21. PubMed ID: 26059356
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nicotinic Acid Phosphoribosyltransferase Regulates Cancer Cell Metabolism, Susceptibility to NAMPT Inhibitors, and DNA Repair.
    Piacente F; Caffa I; Ravera S; Sociali G; Passalacqua M; Vellone VG; Becherini P; Reverberi D; Monacelli F; Ballestrero A; Odetti P; Cagnetta A; Cea M; Nahimana A; Duchosal M; Bruzzone S; Nencioni A
    Cancer Res; 2017 Jul; 77(14):3857-3869. PubMed ID: 28507103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma.
    Guo Q; Han N; Shi L; Yang L; Zhang X; Zhou Y; Yu S; Zhang M
    Oncol Rep; 2019 Sep; 42(3):963-972. PubMed ID: 31322259
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exercise increases the release of NAMPT in extracellular vesicles and alters NAD
    Chong MC; Silva A; James PF; Wu SSX; Howitt J
    Aging Cell; 2022 Jul; 21(7):e13647. PubMed ID: 35661560
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retinal toxicity, in vivo and in vitro, associated with inhibition of nicotinamide phosphoribosyltransferase.
    Zabka TS; Singh J; Dhawan P; Liederer BM; Oeh J; Kauss MA; Xiao Y; Zak M; Lin T; McCray B; La N; Nguyen T; Beyer J; Farman C; Uppal H; Dragovich PS; O'Brien T; Sampath D; Misner DL
    Toxicol Sci; 2015 Mar; 144(1):163-72. PubMed ID: 25505128
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nicotinamide phosphoribosyltransferase can affect metastatic activity and cell adhesive functions by regulating integrins in breast cancer.
    Santidrian AF; LeBoeuf SE; Wold ED; Ritland M; Forsyth JS; Felding BH
    DNA Repair (Amst); 2014 Nov; 23():79-87. PubMed ID: 25263164
    [TBL] [Abstract][Full Text] [Related]  

  • 54. eNAMPT/TLR4 inflammatory cascade activation is a key contributor to SLE Lung vasculitis and alveolar hemorrhage.
    Tumurkhuu G; Casanova NG; Kempf CL; Ercan Laguna D; Camp SM; Dagvadorj J; Song JH; Reyes Hernon V; Travelli C; Montano EN; Yu JM; Ishimori M; Wallace DJ; Sammani S; Jefferies C; Garcia JGN
    J Transl Autoimmun; 2023; 6():100181. PubMed ID: 36619655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Physiological and pathophysiological roles of NAMPT and NAD metabolism.
    Garten A; Schuster S; Penke M; Gorski T; de Giorgis T; Kiess W
    Nat Rev Endocrinol; 2015 Sep; 11(9):535-46. PubMed ID: 26215259
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extracellular nicotinamide phosphoribosyltransferase (NAMPT/visfatin) inhibits insulin-like growth factor-1 signaling and proteoglycan synthesis in human articular chondrocytes.
    Yammani RR; Loeser RF
    Arthritis Res Ther; 2012 Jan; 14(1):R23. PubMed ID: 22289259
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5).
    Torretta S; Colombo G; Travelli C; Boumya S; Lim D; Genazzani AA; Grolla AA
    Cells; 2020 Feb; 9(2):. PubMed ID: 32098202
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nicotinamide phosphorybosiltransferase overexpression in thyroid malignancies and its correlation with tumor stage and with survivin/survivin DEx3 expression.
    Sawicka-Gutaj N; Waligórska-Stachura J; Andrusiewicz M; Biczysko M; Sowiński J; Skrobisz J; Ruchała M
    Tumour Biol; 2015 Sep; 36(10):7859-63. PubMed ID: 25946974
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer Cells.
    Tan B; Dong S; Shepard RL; Kays L; Roth KD; Geeganage S; Kuo MS; Zhao G
    J Biol Chem; 2015 Jun; 290(25):15812-15824. PubMed ID: 25944913
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the nicotinamide adenine dinucleotide (NAD) salvage pathway, to target glioma heterogeneity through mitochondrial oxidative stress.
    Sharma P; Xu J; Williams K; Easley M; Elder JB; Lonser R; Lang FF; Lapalombella R; Sampath D; Puduvalli VK
    Neuro Oncol; 2022 Feb; 24(2):229-244. PubMed ID: 34260721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.